1 month ago
23
An Alabama child has become one of the first patients in the nation to receive a newly approved gene therapy designed to treat a rare form of inherited deafness, state health officials announced last month.
The child, enrolled in Alabama’s ALL Kids program, received Otarmeni at Boston Children’s Hospital during a same-day surgical procedure. The treatment targets profound hearing loss caused by mutations in the OTOF gene.
